Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) Interest Coverage Ratio (2016 - 2020)

Historic Interest Coverage Ratio for Outlook Therapeutics (OTLK) over the last 6 years, with Q2 2020 value amounting to 26.78.

  • Outlook Therapeutics' Interest Coverage Ratio fell 41322.8% to 26.78 in Q2 2020 from the same period last year, while for Jun 2025 it was 105.46, marking a year-over-year change of. This contributed to the annual value of 22.71 for FY2024, which is 821.57% down from last year.
  • Per Outlook Therapeutics' latest filing, its Interest Coverage Ratio stood at 26.78 for Q2 2020, which was down 41322.8% from 9.72 recorded in Q1 2020.
  • In the past 5 years, Outlook Therapeutics' Interest Coverage Ratio registered a high of 1.36 during Q3 2017, and its lowest value of 73.56 during Q2 2016.
  • Moreover, its 5-year median value for Interest Coverage Ratio was 8.28 (2018), whereas its average is 16.95.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first soared by 9428.66% in 2017, then plummeted by 72867.66% in 2018.
  • Over the past 5 years, Outlook Therapeutics' Interest Coverage Ratio (Quarter) stood at 36.38 in 2016, then skyrocketed by 87.82% to 4.43 in 2017, then crashed by 106.61% to 9.15 in 2018, then crashed by 49.63% to 13.69 in 2019, then crashed by 95.55% to 26.78 in 2020.
  • Its Interest Coverage Ratio stands at 26.78 for Q2 2020, versus 9.72 for Q1 2020 and 13.69 for Q4 2019.